Rv0663 Arylsulfatase (EC

Symbol Product Feature Type Start End Strand Length AA Length is TF
Rv0663 atsD Arylsulfatase (EC CDS 756137 758500 + 2 364 787 FALSE

Rv0663 (Arylsulfatase (EC is predicted to be co-regulated in modules bicluster_0189 with residual 0.44 and bicluster_0569 with residual 0.58.

This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 13,000.00 and 13,000.00 for bicluster_0189 and 500.00 and 460.00 for bicluster_0569 respectively.

These modules are enriched for following go terms: glycerol metabolic process, alditol metabolic process, polyol metabolic process, alcohol metabolic process, organic hydroxy compound metabolic proce..., aspartic-type endopeptidase activity, aspartic-type peptidase activity, ATP-dependent DNA helicase activity, DNA-dependent ATPase activity purine-nucleoside phosphorylase activity.

This gene is found to be for growth on cholesterol.

Mutant available?:

Product (LegacyBRC) Product (RefSeq)
Operon # Operon
447 - - -
PATRIC Locus Tag Enzyme Name PATRIC Pathways Transcriptomics


Arylsulfatase C21-Steroid hormone metabolism, Sphingolipid metabolism
Locus Tuberculist Genome View


Locus Tag KEGG Pathways


not assigned to any KEGG Pathway.
BioCyc Gene Page Cellular Overview Map
Link to STRING STRING Network


GI Number Protein ID Blast Conserved Domains
15607803 NP_215177.1 Run
No TFOE experiment results were found
Quantitative Proteomics Data
t-test p-value Cholesterol/Glycerol Ratio
0.530000 3.05

How essentiality calculations were done?

The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.

TRIP log2 fold abundance change

reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.

p-value Untreated:
p-value INH: